CSF1R and glioma: PERTINENT FINDINGS:18F-DPA-714 PET provided complementary information to 18F-FET PET on glioma heterogeneity, allowed the imaging of immune cell dynamics, supported the assessment of brain target engagement, and elucidated CSF-1R inhibition–induced effects in vivo.